Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clinical-stage biopharma company Aprea Therapeutics, Inc. (APRE) Monday announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for APR-1051.